Literature DB >> 18172624

The future of pharmacovigilance: a personal view.

I Ralph Edwards1.   

Abstract

Mesh:

Year:  2008        PMID: 18172624     DOI: 10.1007/s00228-007-0435-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Drug-related hospital admissions.

Authors:  K M Nelson; R L Talbert
Journal:  Pharmacotherapy       Date:  1996 Jul-Aug       Impact factor: 4.705

2.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

3.  Pharmacovigilance. The French system.

Authors:  R J Royer
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

4.  Adverse drug reaction monitoring: doing it the French way.

Authors:  N Moore; M Biour; G Paux; E Loupi; B Begaud; F Boismare; R J Royer
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

5.  The WHO World Alliance for Patient Safety: a new challenge or an old one neglected?

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

Authors:  Munir Pirmohamed; Sally James; Shaun Meakin; Chris Green; Andrew K Scott; Thomas J Walley; Keith Farrar; B Kevin Park; Alasdair M Breckenridge
Journal:  BMJ       Date:  2004-07-03

7.  The Erice Manifesto: for global reform of the safety of medicines in patient care.

Authors: 
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  7 in total
  4 in total

1.  Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database.

Authors:  Piero Impicciatore; Massimiliano Mucci
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

2.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data.

Authors:  Jürgen Stausberg; Joerg Hasford
Journal:  BMC Health Serv Res       Date:  2011-05-29       Impact factor: 2.655

3.  Starting a pharmacovigilance center: Actions for implementation.

Authors:  Mrinmoy Chakrabarty; Vijay Thawani
Journal:  J Pharmacol Pharmacother       Date:  2011-10

4.  Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance.

Authors:  Shinichi Matsuda; Kotonari Aoki; Shiho Tomizawa; Masayoshi Sone; Riwa Tanaka; Hiroshi Kuriki; Yoichiro Takahashi
Journal:  JMIR Public Health Surveill       Date:  2017-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.